What's Available for Induction Therapy in Multiple Myeloma image

What's Available for Induction Therapy in Multiple Myeloma

Jan 19, 2023
05:00PM - 06:00PM EST
Online Event
Overview

Patients are hungry to know what is currently available for Induction Therapy. Common questions that I hear are:

1. What is the standard of care for myeloma induction therapy? Does that vary based on risk stratification?

2. What is the standard of care for induction therapy of myeloma patients that do not qualify/opt-out of transplant?

3. What other options are there for induction therapy? Why would someone receive induction therapy outside of the standard of care (i.e. kidney involvement, frail, etc.)

Learn the answers to these questions and more through the expertise of myeloma specialist Dr. Nisha Joseph. We look forward to learning with you!

Agenda
05:00 PM
Introductions
Audrey Burton-Bethke

Audrey introduces the agenda of the event and featured speaker Dr. Nisha Joseph.

05:05 PM
Presentation
Nisha Joseph, MD

Dr. Nisha Joseph answers the most common questions about Induction Therapy in Multiple Myeloma.

05:35 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators
Healthtree contact Audrey Burton-Bethke

Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Healthtree contact Nisha Joseph, MD

Nisha Joseph, MD

Nisha Joseph, MD is Assistant Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Board certified in hematology and medical oncology, she specializes in treating patients with plasma cell disorders including multiple myeloma and amyloidosis. She is also an active clinical researcher in the fields of multiple myeloma, amyloidosis and bone marrow transplant. Dr. Joseph is a member of the Clinical and Translational Review Committee and the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute, and serves as the director of the Morbidity and Mortality conferences of the Department of Hematology and Oncology. She co-leads the Winship Summer Scholars Program, providing high school students with a unique immersion experience in a cancer research laboratory. Dr. Joseph was named the first H. Jean Khoury Fellow in Leukemia and Bone Marrow Transplant prior to joining the faculty at Winship Cancer Institute. Dr. Joseph holds professional memberships with American Society of Clinical Oncology and American Society of Hematology.